This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Regulatory Affairs, Medical Devices

Clinical expectations of the EU MDR with TÜV SÜD and MedSmart

Posted by on 07 April 2021
Share this article

As the Date of Application (DoA) gets closer, industry is continuing to adapt to the changes the EU MDR brings. In this exclusive interview, Rebecca Brady from the MedTech Series discusses the clinical expectations of the EU MDR, the future challenges for industry and the impact of the global COVID-19 pandemic on the regulatory deadlines.

Matthias Fink from TÜV SÜD, and Dona Occhipinti from MedSmart, provide their perspectives on how industry can prepare for the DoA but more importantly, life with the EU MDR long term.

Share this article

Sign up for our MedTech Monthly newsletter

Get the latest content and updates straight to your inbox